Vikas Satyananda
Impact in
-
- Immune cells in cancer
Papers in
- Co-authors
- Masanori Oshi (7 shared papers)Kazuaki Takabe (7 shared papers)David K. C. Cooper (8 shared papers)Hidetaka Hara (7 shared papers)Mohamed Ezzelarab (5 shared papers)Yoshihisa Tokumaru (4 shared papers)Itaru Endo (6 shared papers)Burcin Ekser (5 shared papers)
- Journals
- Xenotransplantation (3 papers)Annals of Surgical Oncology (2 papers)Transplant Immunology (2 papers)Transplantation (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Vikas Satyananda
24 papers receiving 631 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 112
- Immunology 139
- Surgery 284
- Genetics 178
- Transplantation 16
Countries citing papers authored by Vikas Satyananda
This map shows the geographic impact of Vikas Satyananda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Satyananda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Satyananda more than expected).
Fields of papers citing papers by Vikas Satyananda
This network shows the impact of papers produced by Vikas Satyananda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Satyananda. The network helps show where Vikas Satyananda may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikas Satyananda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 139 | |
| 2 | 2014 | 111 | |
| 3 | KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival. | 2020 | 88 |
| 4 | 2015 | 52 | |
| 5 | 2015 | 51 | |
| 6 | 2013 | 40 | |
| 7 | 2021 | 28 | |
| 8 | Angiogenesis is associated with an attenuated tumor microenvironment, aggressive biology, and worse survival in gastric cancer patients. | 2021 | 27 |
| 9 | Sphingosine 1-phosphate (S1P) produced by sphingosine kinase 1 (SphK1) and exported via ABCC1 is related to hepatocellular carcinoma (HCC) progression. | 2021 | 24 |
| 10 | 2021 | 16 | |
| 11 | 2013 | 12 | |
| 12 | 2014 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2013 | 6 | |
| 15 | 2015 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2010 | 1 |
About Vikas Satyananda
Vikas Satyananda is a scholar working on Surgery, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 637 indexed citations. Recurring topics across this work include Xenotransplantation and immune response (9 papers), Pancreatic function and diabetes (3 papers), Virus-based gene therapy research (3 papers), Transplantation: Methods and Outcomes (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Pancreatitis Pathology and Treatment (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (112 citations), Immunology (139 citations), Surgery (284 citations), Genetics (178 citations) and Transplantation (16 citations). Vikas Satyananda has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Masanori Oshi, Kazuaki Takabe, David K. C. Cooper, Hidetaka Hara, Mohamed Ezzelarab, Yoshihisa Tokumaru, Itaru Endo, Burcin Ekser, Li Yan and Nobuhisa Matsuhashi. Their work appears in journals such as Xenotransplantation, Annals of Surgical Oncology, Transplant Immunology, Transplantation and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.